Biocompatibility and Antimicrobial Studies of Pharmaceutical Formulations
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 35
Special Issue Editors
Interests: assessment of biocompatibility; drug delivery system formulation; application of macromolecules; characterization of dosage forms; in vitro dissolution studies; SEDDS
Special Issues, Collections and Topics in MDPI journals
Interests: cytotoxicity; cell viability; pharmaceutical technology; preservatives; galleria mellonella; pharmaceutical formulation; antimicrobials; biocompatibility; pharmaceutics
Special Issues, Collections and Topics in MDPI journals
Interests: topical drug delivery; self-emulsifying drug delivery systems; nanocarriers; surfactants; in vitro and in vivo studies; pharmaceutical technology; drug release; skin permeation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
A necessary step in pharmaceutical research is the investigation into the biocompatibility of the new formulation in order to ensure its tolerability. In vitro cell cultures and ex vivo and in vivo animal model systems provide different levels of valuable information about the safety of the developed drug delivery system, and it is essential that one must be aware of the advantages and limitations of each available technique, thus only in considering these factors can the correct conclusion be made while evaluating the results of the formulation. Biocompatibility studies are highly important in the case of antimicrobial formulations, being the most common mechanism of action affecting non-microbial cells, and as such, while the given drug or drugs are effectively inhibiting or terminating the targeted microorganisms, considerable damage impacts the host organism as well.
The Special Issue cordially welcomes all manuscripts in which the biocompatibility of small molecules, herbal extracts, polymers, or complete drug delivery systems are evaluated, and the antimicrobial effect is tested also. Research articles or reviews in which the comparison of different methods, the relationship of biocompatibility, and the antimicrobial effects are discussed are also covered by the Special Issue.
Prof. Dr. Ildikó Bácskay
Dr. Dániel Nemes
Dr. Liza Józsa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobials
- biocompatibility
- in vivo toxicity
- cytotoxicity
- antifungals
- antibacterial
- antibiotics
- drug delivery systems
- in vitro and in vivo models
- new biologically active agents
